Pembina Pipeline (PBA) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.66 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +12.74%. A quarter ago, it was expected that this oil and gas transportation and services company would post earnings of $0.45 per share when it actually produced earnings of $0.31, delivering a surprise of -31.11%. ...

securities you may be entitled to compensation without payment of any out of pocket fees or costs through a con...[Back to Newsroom]## Wish your news had this kind of reach?[Sign Up][Learn About Business Wire] Rosen Law Firm Urges Lakeland Industries, Inc. (NASDAQ: LAKE) Stockholders to Contact the Firm for Information About Their RightsFeb 26, 2026 7:46 PM Eastern Standard Time# Rosen Law Firm Urges Lakeland Industries, Inc. (NASDAQ: LAKE) Stockholders to Contact the Firm for Information About Their Rights ...

Twitter co-founder Jack Dorsey is axing more than 4,000 employees at his fintech company Block — slashing the workforce by nearly half in what he called a necessary shift toward ‘intelligence tools.’Dorsey sent a letter to shareholders saying the company, which owns Square, Cash App and Afterpay, will reduce 10,205 staff to just under 6,00. 3 Jack Dorsey’s Block, which owns Square and Cash App, is cutting 4,000 jobs, or 40% of its workforce. Bloomberg via Getty Images 3 The company said it expects to in ...

Twitter co-founder Jack Dorsey is axing more than 4,000 employees at his fintech company Block — slashing the workforce by nearly half in what he called a necessary shift toward ‘intelligence tools.’Dorsey sent a letter to shareholders saying the company, which owns Square, Cash App and Afterpay, will reduce 10,205 staff to just under 6,00. 3 Jack Dorsey’s Block, which owns Square and Cash App, is cutting 4,000 jobs, or 40% of its workforce. Bloomberg via Getty Images 3 The company said it expects to in ...

Brendan, a Pennsylvanian by birth:-Completed a Ph.D. at Stanford University in the field of organic synthesis (2009). -Worked for a major pharmaceutical company (Merck, 2009-2013).-Worked in biotech including start-ups (Theravance/Aspira) prior to securing employment at Caltech.-First employee and co-founder of 1200 Pharma as it spun out of Caltech garnering major investment (into the 8 figures).-Remains an avid investor, focused on market trends and especially biotechnology stocks.Analyst’s Disclosure: I/w ...

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided financial results and an operational update for the period ended December 31, 2025 (H1 FY2026). FINANCIAL HIGHLIGHTS FOR H1 FY20261 Performance driven by successful commercial launch of Ryoncil® Total revenue of US$51.3 million (A$78.3 million),2 up from US$3.2 million.Successful U.S. commercial launch of Ryoncil® (remestemcel-L-rknd) ...

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the “Class Period”), of the important April 13, 2026 lead plaintiff deadline. SO WHAT: If you purchased uniQure ordinary shares during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHA ...

Core Insights - Alignment Healthcare reported a revenue of $1.01 billion for the quarter ended December 2025, marking a 44.4% increase year-over-year and exceeding the Zacks Consensus Estimate by 1.1% [1] - The company's EPS was -$0.05, an improvement from -$0.16 in the same quarter last year, resulting in a surprise of 67.04% compared to the consensus estimate of -$0.15 [1] Financial Performance Metrics - Medical Benefit Ratio was reported at 87.7%, which is better than the estimated 89.1% by analysts [4] - Health Plan Membership at the end of the quarter was 236,300, slightly above the estimated 233,752 [4] - Revenues from earned premiums reached $1 billion, surpassing the estimate of $990.31 million, reflecting a 45.1% increase year-over-year [4] - Other revenues were reported at $9.01 million, below the estimated $10.57 million, indicating a 4.7% decline compared to the previous year [4] Stock Performance - Over the past month, shares of Alignment Healthcare have decreased by 8.8%, contrasting with a 0.6% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Financial Performance - Progyny reported revenue of $318.4 million for the quarter ended December 2025, reflecting a 6.7% increase year-over-year [1] - Earnings per share (EPS) for the quarter was $0.48, up from $0.42 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $303.93 million by 4.76% [1] - The company delivered an EPS surprise of 25.49%, with the consensus EPS estimate being $0.38 [1] Key Metrics - Utilization for female-only services was 0.5%, matching the two-analyst average estimate [4] - Average members reached 6,707, surpassing the two-analyst average estimate of 6,586 [4] - Revenue from pharmacy benefit services was $109.8 million, slightly below the estimated $110.78 million, representing a year-over-year decrease of 1.1% [4] - Revenue from fertility benefit services was $208.6 million, exceeding the three-analyst average estimate of $192.06 million, with a year-over-year increase of 11.3% [4] Stock Performance - Progyny's shares have returned -13.1% over the past month, while the Zacks S&P 500 composite has increased by 0.6% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - CubeSmart (CUBE) reported a revenue of $282.69 million for the quarter ended December 2025, marking a year-over-year increase of 22.2% and a surprise of +0.79% over the Zacks Consensus Estimate of $280.47 million [1] - The earnings per share (EPS) for the same period was $0.64, compared to $0.45 a year ago, although it fell short of the consensus EPS estimate of $0.66, resulting in an EPS surprise of -2.75% [1] Financial Performance Metrics - Property management fee income was reported at $9.64 million, which is below the three-analyst average estimate of $10.16 million, reflecting a year-over-year decline of -7.3% [4] - Rental income reached $240.93 million, slightly below the $243.88 million average estimate based on two analysts, but showed a year-over-year increase of +5.6% [4] - Other property-related income was reported at $32.13 million, exceeding the two-analyst average estimate of $30.87 million, with a year-over-year change of +10.4% [4] - Net Earnings Per Share (Diluted) was $0.35, compared to the two-analyst average estimate of $0.37 [4] Stock Performance - CubeSmart's shares have returned +7.1% over the past month, outperforming the Zacks S&P 500 composite's +0.6% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]